Literature DB >> 32978701

Reply to "Comment on: Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients".

Phillip M Kemp Bohan1, Daniel W Nelson2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32978701     DOI： 10.1245/s10434-020-09170-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  2 in total

1.  ASO Author Reflections: Contemporary Analysis of Impact of Lymphadenectomy on Survival in Nonmetastatic Gallbladder Cancer.

Authors:  Phillip M Kemp Bohan; Daniel W Nelson; Timothy J Vreeland
Journal:  Ann Surg Oncol       Date:  2021-02-09       Impact factor: 5.344

2.  ASO Author Reflection: Trends and Impact of Adjuvant Chemotherapy in Resected Gallbladder Cancer: Going Beyond Trial Data.

Authors:  Phillip M Kemp Bohan; Daniel W Nelson
Journal:  Ann Surg Oncol       Date:  2020-08-05       Impact factor: 5.344
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.